$VRSK

Shavel Lee sold $696K of VRSK

Shavel Lee (Chief Executive Officer) sold 3,535 shares of Verisk Analytics, Inc. (VRSK) at $196.94 ($0.70M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shavel Lee
Published Aug 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:15 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
medium confidence
Mentioned
$VRSK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

This is a scheduled open-market sale by the CEO under a pre-arranged 10b5-1 plan, with no accompanying corporate, financial, or operational updates in the text.

02

Market read

Traders may note the CEO’s scheduled sale for sentiment/positioning, but there is no new fundamental catalyst in the filing details provided.

03

What to watch

The article does not state total planned volume, whether this sale is part of a larger tranche, or any concurrent insider buys, so the signal strength is uncertain.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-03 (intra-day disclosure)

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Verisk Analytics, Inc.

Company-level read

Ticker impact

$VRSKNeutralMedium confidence
Context

Verisk CEO Shavel Lee filed a Form 4 selling 3,535 shares at $196.94 on 2026-08-03 under a 10b5-1 plan.

Expected impact

Likely minimal near-term price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a scheduled open-market sale by the CEO with a pre-arranged 10b5-1 plan, and the article contains no accompanying operational or guidance change.

Market effects

Insider-sale headlines can slightly influence sentiment across data/analytics peers, but this specific disclosure is company-specific and not sector-resetting.

No clear regional spillover; US-listed issuer filing only.

Limited global relevance; no deal, regulation, or macro linkage described.

Counterpoint

Even with a 10b5-1 plan, repeated or sizable CEO sales can still be read by some traders as a mild bearish sentiment input, especially if liquidity/positioning is tight.

Key entities

  • Verisk Analytics, Inc.

    US-listed data analytics company subject of the Form 4 insider transaction.

  • Shavel Lee

    CEO and director who executed the reported sale.

  • 10b5-1 plan

    Pre-arranged plan indicating the sale was scheduled rather than discretionary.

Related articles

$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.